Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )
ClinicalTrials.gov Identifier:
NCT00406809
First received: November 30, 2006
Last updated: November 10, 2016
Last verified: November 2016